Contact Us

Your Name (required)

Your Email (required)

Your Phone (required)


Interested In... (required)

Your Message

API manufacturing

WDSrx Quality Assurance team for reviews regulatory guidelines for post-pandemic resilience

Post-Pandemic Resilience And Pharmaceutical Logistics

  Business disruption from the Coronavirus pandemic exposes a weakness in the United States pharmaceutical supply chain. United States government officials are currently working on creating new proposals and finding potential solutions for post-pandemic resilience. Before the outbreak of the virus, the United States relied heavily on other countries for manufacturing. Approximately 72% of all pharmaceutical ingredients were supplied overseas, specifically, 13% in China. This is problematic ...

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at or (561) 998-3885 x316.